Cardiac resynchronization therapy: who benefits?

Area of Science:

• Cardiology
• Medical Devices
• Heart Failure Management

Background:

• Cardiac resynchronization therapy (CRT) is proven to improve heart failure symptoms, hospitalizations, remodeling, and mortality in selected patients.
• Current guidelines identify patients likely to benefit, yet approximately 30% do not respond favorably.
• Existing guidelines may exclude patients who could potentially benefit from CRT.

Purpose of the Study:

• To evaluate factors predicting patient response to CRT.
• To identify patient subgroups most likely to benefit from CRT.
• To refine patient selection criteria for CRT.

Main Methods:

• Review of evidence on factors influencing CRT response.
• Analysis of QRS morphology, QRS duration, cardiomyopathy etiology, and rhythm.
• Consideration of antibradycardia pacing needs and baseline New York Heart Association (NYHA) class.

Main Results:

• Patient selection for CRT requires assessment of factors beyond standard criteria, including QRS morphology (especially left bundle-branch block), QRS duration, and cardiomyopathy etiology.
• Baseline NYHA class influences the type of benefit expected; early-stage patients may see structural improvements, while severe cases might gain functional capacity.
• Factors like rhythm and need for pacing also impact CRT outcomes.

Conclusions:

• Optimizing CRT benefits involves considering a broader range of patient-specific factors.
• Accurate patient selection is crucial for maximizing positive responses and minimizing detrimental effects of CRT.
• This review aids in better determining which patients will gain the most from this evolving therapy.